![On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation | Communications Biology On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-021-02513-3/MediaObjects/42003_2021_2513_Fig1_HTML.png)
On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation | Communications Biology
![Cells | Free Full-Text | Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination Cells | Free Full-Text | Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination](https://www.mdpi.com/cells/cells-10-01952/article_deploy/html/images/cells-10-01952-g001.png)
Cells | Free Full-Text | Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
![Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine](https://www.mdpi.com/diagnostics/diagnostics-11-01135/article_deploy/html/images/diagnostics-11-01135-g001.png)
Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
![Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan | Scientific Reports Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-82428-5/MediaObjects/41598_2021_82428_Fig1_HTML.png)
Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan | Scientific Reports
![Constructive approach for synthesis of a functional IgG using a reconstituted cell-free protein synthesis system | Scientific Reports Constructive approach for synthesis of a functional IgG using a reconstituted cell-free protein synthesis system | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36691-8/MediaObjects/41598_2018_36691_Fig1_HTML.png)
Constructive approach for synthesis of a functional IgG using a reconstituted cell-free protein synthesis system | Scientific Reports
![Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies | Science Translational Medicine Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aax1315/asset/7c5080fe-4112-4ad0-af46-9f7162663005/assets/graphic/aax1315-f1.jpeg)
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies | Science Translational Medicine
![The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement | Nature Communications The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33764-1/MediaObjects/41467_2022_33764_Fig1_HTML.png)
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement | Nature Communications
![Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 - Hou - 2020 - Clinical & Translational Immunology - Wiley Online Library Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 - Hou - 2020 - Clinical & Translational Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ae0b156a-70d4-41de-943a-2173876db40c/cti21136-fig-0001-m.jpg)
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 - Hou - 2020 - Clinical & Translational Immunology - Wiley Online Library
![Goat anti-Mouse IgG (H+L) Secondary Antibody, HRP, Invitrogen 2 mL; HRP:Antibodies, | Fisher Scientific Goat anti-Mouse IgG (H+L) Secondary Antibody, HRP, Invitrogen 2 mL; HRP:Antibodies, | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/antibodies/31430-Goat-anti-Mouse-IgG-HRP-WB20180301132853_20180831134936.jpg-650.jpg)
Goat anti-Mouse IgG (H+L) Secondary Antibody, HRP, Invitrogen 2 mL; HRP:Antibodies, | Fisher Scientific
![Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges, Part 1 - BioProcess InternationalBioProcess International Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges, Part 1 - BioProcess InternationalBioProcess International](https://bioprocessintl.com/wp-content/uploads/2017/12/15-11-Chamow-F1new.jpg)